These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30355740)

  • 41. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.
    Mattarozzi K; Bellucci C; Campi C; Cipolli C; Ferri R; Franceschini C; Mazzetti M; Russo PM; Vandi S; Vignatelli L; Plazzi G
    Sleep Med; 2008 May; 9(4):425-33. PubMed ID: 17681883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ
    Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment Options for Narcolepsy.
    Barateau L; Lopez R; Dauvilliers Y
    CNS Drugs; 2016 May; 30(5):369-79. PubMed ID: 27155860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder.
    Luppi PH; Clément O; Sapin E; Gervasoni D; Peyron C; Léger L; Salvert D; Fort P
    Sleep Med Rev; 2011 Jun; 15(3):153-63. PubMed ID: 21115377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Control of motoneuron function and muscle tone during REM sleep, REM sleep behavior disorder and cataplexy/narcolepsy.
    Peever J
    Arch Ital Biol; 2011 Dec; 149(4):454-66. PubMed ID: 22205591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Narcolepsy: new understanding of irresistible sleep.
    Krahn LE; Black JL; Silber MH
    Mayo Clin Proc; 2001 Feb; 76(2):185-94. PubMed ID: 11213307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Searching for a marker of REM sleep behavior disorder: submentalis muscle EMG amplitude analysis during sleep in patients with narcolepsy/cataplexy.
    Ferri R; Franceschini C; Zucconi M; Vandi S; Poli F; Bruni O; Cipolli C; Montagna P; Plazzi G
    Sleep; 2008 Oct; 31(10):1409-17. PubMed ID: 18853938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of acute administration of sodium oxybate on nocturnal sleep polysomnography and on multiple sleep latency test in narcolepsy with cataplexy.
    Plazzi G; Pizza F; Vandi S; Aricò D; Bruni O; Dauvilliers Y; Ferri R
    Sleep Med; 2014 Sep; 15(9):1046-54. PubMed ID: 25087195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. REM sleep enhancement and behavioral cataplexy following orexin (hypocretin)-II receptor antisense perfusion in the pontine reticular formation.
    Thakkar MM; Ramesh V; Cape EG; Winston S; Strecker RE; McCarley RW
    Sleep Res Online; 1999; 2(4):112-20. PubMed ID: 11382892
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Images: Facial cataplexy with demonstration of persistent eye movements.
    Schneider L; Ellenbogen J
    J Clin Sleep Med; 2020 Jan; 16(1):157-159. PubMed ID: 31957646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Motor disturbances during non-REM and REM sleep in narcolepsy-cataplexy: a video-polysomnographic analysis.
    Frauscher B; Gschliesser V; Brandauer E; Schönwald SV; Falkenstetter T; Ehrmann L; Tokmak I; Poewe W; Högl B
    J Sleep Res; 2011 Dec; 20(4):514-21. PubMed ID: 21261767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS; Guilleminault C
    Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of neurochemical abnormalities in patients with narcolepsy with cataplexy: An in vivo brain proton MR spectroscopy study.
    Tonon C; Franceschini C; Testa C; Manners DN; Poli F; Mostacci B; Mignot E; Montagna P; Barbiroli B; Lodi R; Plazzi G
    Brain Res Bull; 2009 Sep; 80(3):147-50. PubMed ID: 19463917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cataplexy: 'tonic immobility' rather than 'REM-sleep atonia'?
    Overeem S; Lammers GJ; van Dijk JG
    Sleep Med; 2002 Nov; 3(6):471-7. PubMed ID: 14592141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Narcolepsy: etiology, clinical features, diagnosis and treatment].
    Zawilska JB; Woldan-Tambor A; Płocka A; Kużajska K; Wojcieszak J
    Postepy Hig Med Dosw (Online); 2012 Oct; 66():771-86. PubMed ID: 23175331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pineal gland, cataplexy, and multiple sclerosis.
    Sandyk R
    Int J Neurosci; 1995 Dec; 83(3-4):153-63. PubMed ID: 8869424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate.
    Mamelak M
    Prog Neurobiol; 2009 Oct; 89(2):193-219. PubMed ID: 19654034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.